Daily Market Briefing

2026-10-29 · Money Checkup market briefing

# Tech Selloff Masks a Broad Rally in Defensive Stocks and Small Caps

The broad market slipped into the red today, but the headline tells only part of the story. While the Nasdaq Composite dropped 1.38% and the S&P 500 fell 0.30%, smaller stocks surged: the Russell 2000 gained 1.01%, signaling a rotation away from large-cap technology toward value and defensive trades. The real action wasn't in the indices—it was in individual stock moves, which ranged from stunning gains to sharp reversals.

The day's clearest trend was the wholesale repricing of beaten-down or previously overlooked names. GLAUKOS (GKOS), a medical-device firm, led gainers with a 33.6% jump, joined by ADT security systems (+33.2%), Bausch Health (BHC, +28.8%), and Teladoc telehealth (TDOC, +26.9%). Crocs (CROX) also popped 25.5%. These aren't typically momentum stocks—many trade in overlooked corners of the market—suggesting investors were rotating into recovery plays and names left for dead after longer downturns. The Garments and Clothing sector (+19.8%, across five companies including CINTAS and VF Corp) and Diversified Commercial Services (+17.7%, a 17-company cohort) both posted solid gains, consistent with a shift toward steadier, less capital-intensive businesses.

By contrast, technology and growth stocks took the harder hit. Semiconductor names—the heaviest represented sector in the broader market with 61 companies—fell 11.7% on average, dragging down NVIDIA, Broadcom, and Micron. ServiceNow (NOW, -26.9%), a major software play, dropped sharply. The weakness in semiconductors and software suggests fund rebalancing or profit-taking from the largest positions, which have dominated index returns for months. Xerox (XRX, -40.3%) suffered the day's steepest loss, likely tied to operational or strategic concerns; the copier/printer giant has faced structural headwinds for years. Biotech also stumbled, with IOVANCE Biotherapeutics (IOVA, -35.4%) and Alnylam Pharmaceuticals (ALNY, -25.1%) both plummeting—possible reactions to clinical data or regulatory news not detailed in today's briefing.

Precious metals and mining stocks weakened sharply, with the Precious Metals sector down 11.3% and Other Metals and Minerals down 27.0%. This suggests a broad pullback from commodities, perhaps reflecting a stronger dollar or softening demand expectations. Five companies are currently flagged with going-concern audit warnings—including Entrada Therapeutics (TRDA), FS KKR Capital (FSK), and Innovative Industrial Properties (IIPR)—a reminder that even in a rising market, individual credit risk can concentrate in overlooked corners. Investors reviewing these names should note the substantial doubt language in their audit opinions.

On the earnings side, six companies filed fresh 10-K annual reports this week. Commercial Metals (CMC) posted the strongest Health Score at 71.7, while Jabil (JBL) came in at 54.4—a wider spread that underscores the value of reviewing fundamentals stock-by-stock rather than betting on sector rotation alone. Use Money Checkup's screener to pull the latest filings and cross-check Health Scores against the stocks showing the biggest moves; today's winners and losers may reveal hidden quality or hidden risk.